Kestra Medical Technologies, Ltd. to Report First Quarter Fiscal 2026 Financial Results
Kestra Medical Technologies (Nasdaq: KMTS), a wearable medical device and digital healthcare company, has scheduled its first quarter fiscal 2026 earnings release for Thursday, September 11.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Kestra Medical Technologies (Nasdaq: KMTS), a wearable medical device and digital healthcare company, has scheduled its first quarter fiscal 2026 earnings release for Thursday, September 11. The company will host a conference call at 4:30 p.m. Eastern Time to discuss the results.
Interested participants can access the live and archived webcast through the "Events" section of Kestra's investor relations website and are advised to register at least 10 minutes before the call begins.
Details
News Market Reaction – KMTS
On Aug 28, the day this news came out, KMTS closed 1.61% below the previous close.
Data tracked by StockTitan Argus for the Aug 28 session.
AI-generated analysis. How Rhea-AI works. Not financial advice.
KIRKLAND, Wash., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a wearable medical device and digital healthcare company, today announced that it will report first quarter fiscal 2026 financial results on Thursday, September 11. Management will host a corresponding conference call at 4:30 p.m. Eastern Time.
A live and archived webcast of the conference call will be available in the “Events” section of the investor relations website. Participants are encouraged to register on the website at least 10 minutes prior to the start of the conference call.
About Kestra
Kestra Medical Technologies, Ltd. is a commercial-stage wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. For more information, visit www.kestramedical.com.
Investor contact Neil Bhalodkar neil.bhalodkar@kestramedical.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.